{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:12:49Z","timestamp":1780359169248,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10549-025-07738-y","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:26:38Z","timestamp":1748773598000},"page":"467-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Breast imaging recommendations for young females (age &lt;\u200940 years) with \u2265\u200920% lifetime breast cancer risk: practice patterns at a specialized clinic"],"prefix":"10.1007","volume":"212","author":[{"given":"Alexandra","family":"Wehbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisher","family":"Katlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marybeth","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Knust","family":"Graichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Bychkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Scheib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia E.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3602-2351","authenticated-orcid":false,"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,1]]},"reference":[{"key":"7738_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","volume":"95","author":"AN Freedman","year":"2003","unstructured":"Freedman AN, Graubard BI, Rao SR et al (2003) Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95:526\u2013532","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN et al (2019) BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 21:1708\u20131718","journal-title":"Genet Med"},{"key":"7738_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1200\/JOP.2010.000107","volume":"7","author":"WL Owens","year":"2011","unstructured":"Owens WL, Gallagher TJ, Kincheloe MJ et al (2011) Implementation in a large health system of a program to identify women at high risk for breast cancer. J Oncol Pract 7:85\u201388","journal-title":"J Oncol Pract"},{"key":"7738_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clbc.2012.03.002","volume":"12","author":"C Shah","year":"2012","unstructured":"Shah C, Berry S, Dekhne N et al (2012) Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience. Clin Breast Cancer 12:215\u2013218","journal-title":"Clin Breast Cancer"},{"key":"7738_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/1055-9965.EPI-13-1380","volume":"23","author":"CP Kaplan","year":"2014","unstructured":"Kaplan CP, Livaudais-Toman J, Tice JA et al (2014) A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev 23:1245\u20131253","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7738_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00072","volume":"3","author":"X Jiang","year":"2019","unstructured":"Jiang X, McGuinness JE, Sin M et al (2019) Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report. JCO Clin Cancer Inform 3:1\u20138","journal-title":"JCO Clin Cancer Inform"},{"key":"7738_CR7","unstructured":"National Comprehensive Cancer Network. Breast Cancer Screening and Diagnosis. Version 2.2024. April 9, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf. Accessed July 22, 2024. ."},{"key":"7738_CR8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ET, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society. JAMA 314:1599\u20131614","journal-title":"JAMA"},{"key":"7738_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75\u201389","journal-title":"CA Cancer J Clin"},{"key":"7738_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamaoncol.2019.3876","volume":"6","author":"T Mukama","year":"2020","unstructured":"Mukama T, Kharazmi E, Xu X et al (2020) Risk-adapted starting age of screening for relatives of patients with breast cancer. JAMA Oncol 6:68\u201374","journal-title":"JAMA Oncol"},{"key":"7738_CR11","unstructured":"U.S. Centers for Disease Control and Prevention. Cancers by Age, Sex, Race and Ethnicity. https:\/\/gis.cdc.gov\/Cancer\/USCS\/#\/Demographics\/. Accessed July 22, 2024. ."},{"key":"7738_CR12","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cncr.34365","volume":"128","author":"DD Durham","year":"2022","unstructured":"Durham DD, Abraham LA, Roberts MC et al (2022) Breast cancer incidence among women with a family history of breast cancer by relative\u2019s age at diagnosis. Cancer 128:4232\u20134240","journal-title":"Cancer"},{"key":"7738_CR13","doi-asserted-by":"crossref","unstructured":"Force USPST: Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 151:716\u201326, W-236, 2009","DOI":"10.7326\/0003-4819-151-10-200911170-00008"},{"key":"7738_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/CEJ.0000000000000310","volume":"26","author":"L Soguel","year":"2017","unstructured":"Soguel L, Durocher F, Tchernof A et al (2017) Adiposity, breast density, and breast cancer risk: epidemiological and biological considerations. Eur J Cancer Prev 26:511\u2013520","journal-title":"Eur J Cancer Prev"},{"key":"7738_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/jnci\/djj331","volume":"98","author":"WE Barlow","year":"2006","unstructured":"Barlow WE, White E, Ballard-Barbash R et al (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204\u20131214","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF, Byng JW, Jong RA et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian national breast screening study. J Natl Cancer Inst 87:670\u2013675","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1158\/1055-9965.715.13.5","volume":"13","author":"PM Vacek","year":"2004","unstructured":"Vacek PM, Geller BM (2004) A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 13:715\u2013722","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7738_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","volume":"92","author":"MT Mandelson","year":"2000","unstructured":"Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081\u20131087","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djh269","volume":"96","author":"DS Buist","year":"2004","unstructured":"Buist DS, Porter PL, Lehman C et al (2004) Factors contributing to mammography failure in women aged 40\u201349 years. J Natl Cancer Inst 96:1432\u20131440","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR20","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381:2091\u20132102","journal-title":"N Engl J Med"},{"key":"7738_CR21","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","volume":"20","author":"S Saadatmand","year":"2019","unstructured":"Saadatmand S, Geuzinge HA, Rutgers EJT et al (2019) MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol 20:1136\u20131147","journal-title":"Lancet Oncol"},{"key":"7738_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10549-010-0868-1","volume":"124","author":"MA Price","year":"2010","unstructured":"Price MA, Butow PN, Charles M et al (2010) Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat 124:509\u2013519","journal-title":"Breast Cancer Res Treat"},{"key":"7738_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12885-017-3180-1","volume":"17","author":"NH Labrie","year":"2017","unstructured":"Labrie NH, Ludolph R, Schulz PJ (2017) Investigating young women\u2019s motivations to engage in early mammography screening in Switzerland: results of a cross-sectional study. BMC Cancer 17:209","journal-title":"BMC Cancer"},{"key":"7738_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jnci\/djab150","volume":"114","author":"IW Pan","year":"2022","unstructured":"Pan IW, Oeffinger KC, Shih YT (2022) Cost-sharing and out-of-pocket cost for women who received mri for breast cancer screening. J Natl Cancer Inst 114:254\u2013262","journal-title":"J Natl Cancer Inst"},{"key":"7738_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.101995","volume":"74","author":"LT Walji","year":"2021","unstructured":"Walji LT, Murchie P, Lip G et al (2021) Exploring the influence of rural residence on uptake of organized cancer screening\u2014A systematic review of international literature. Cancer Epidemiol 74:101995","journal-title":"Cancer Epidemiol"},{"key":"7738_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jacr.2014.03.022","volume":"11","author":"T Onega","year":"2014","unstructured":"Onega T, Hubbard R, Hill D et al (2014) Geographic access to breast imaging for US women. J Am Coll Radiol 11:874\u2013882","journal-title":"J Am Coll Radiol"},{"key":"7738_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8893","volume":"6","author":"T Chen","year":"2023","unstructured":"Chen T, Kharazmi E, Fallah M (2023) Race and ethnicity-adjusted age recommendation for initiating breast cancer screening. JAMA Netw Open 6:e238893","journal-title":"JAMA Netw Open"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07738-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:05:31Z","timestamp":1751277931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07738-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7738"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07738-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TAK reports speaker honoraria for Exact Sciences, compensated service on the FES Steering Committee for GE Healthcare, compensated service for advisory board role for Veracyte, and compensated service as faculty for PrecisCa cancer information service. AL reports speaker fees for Novartis. The remaining authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Brigham and Women\u2019s Hospital IRB; a waiver of consent was obtained. We conducted the study in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}